Trials / Completed
CompletedNCT04893057
COVID-19 Seroprevalence in Pregnant Women and Blood Donors
SARS-CoV-2 sERoprévalences Dans la Population Des Femmes Enceintes et Donneurs de Sang
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 797 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to determine whether these measures are representative of the general population.
Conditions
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2023-01-04
- Completion
- 2023-01-04
- First posted
- 2021-05-19
- Last updated
- 2024-10-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04893057. Inclusion in this directory is not an endorsement.